Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

ELCC 2019 1000x250

The abstract submission system is open!

Submit Your Abstract

Abstract submission deadlines


Date and time

  • Abstracts
  • Trial in Progress
  • Intent to submit LBA

9 January 2019, 21:00 CET*

Late-breaking abstracts (LBA)

5 March 2019, 21:00 CET*

*CET = Central European Time

Abstract submission categories

  • Tumour biology and pathology
  • Translational research
  • Prevention, early detection, epidemiology, tobacco control
  • Imaging and staging
  • SCLC
  • Early stage NSCLC
  • Locally advanced NSCLC
  • Advanced NSCLC
  • Metastases to and from the lung
  • Mesothelioma
  • Miscellaneous

Late-breaking abstracts (LBA)

Late-breaking abstracts may be submitted for high quality, new research findings with implications for clinical practice or understanding of disease processes. The work must not have been previously published in any publication in a peer review setting or presented at a meeting of any other scientific organisation prior to ELCC 2019. 

A skeleton indicating the type of data that will be available by the late-breaking abstract deadline must be submitted online by the regular abstract deadline on 9 January 2019. 

Submitters of preliminary versions receiving approval to proceed must submit the final LBA by 5 March 2019.

Trial in progress abstracts (TiP)

Trial in Progress (TiP) abstracts in all phases of clinical research (phases I to III) may be submitted to ELCC 2019. 

It is expected that abstracts submitted as Trial in Progress (TiP) are ongoing trials that have not reached any protocol-specified endpoints for analysis and consequently will only require the completion of two (2) sections:

  • Background
  • Trial design 

Please note:

  • Recruitment must have already begun or have been completed by the abstract submission deadline of 9 January 2019.
  • Abstracts including results or preliminary data will be rejected.
  • Encore TiP abstracts will NOT be accepted. 

Trial in Progress abstracts will be considered for Poster presentation only.

Presentation options for accepted abstracts

The ELCC 2019 Scientific Committee will select abstracts for presentation during the Congress and determine the format of the presentations from the following possibilities:

  • Proffered Paper: Oral presentations by authors presenting original data of superior quality, followed by expert discussion and perspectives.
  • Mini Oral: Short presentation by authors with comment and interactive audience discussion led by and an invited expert.
  • Poster: Display sessions for review, discussion and questions. Presenting authors must be available for Q&A to represent their work.

Merit Awards

A restricted number of Merit Awards are reserved for candidates under 40 years of age. Selection of Merit Award recipients is based on the quality of accepted abstracts as reviewed by the ELCC 2019 Scientific Committee.

More information can be found in the Abstract regulations.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings